UNITED THERAPEUTICS

UTHR
Delayed Quote. Delayed  - 02/26 04:00:00 pm
167.18USD -0.96%
Upcoming events on UNITED THERAPEUTICS CORPORATION
05/05/21 Q1 2021 Earnings Release (Projected)
08/04/21 Interim 2021 Earnings Release (Projected)
11/03/21 Q3 2021 Earnings Release (Projected)
02/23/22 FY 2021 Earnings Release (Projected)

Past events on UNITED THERAPEUTICS CORPORATION
02/24/21 | 09:00amFY 2020 Earnings Call
02/24/21FY 2020 Earnings Release
01/19/21 | 04:30pmTyvaso Study Results Call
01/11/21 | 10:50amJP Morgan Healthcare Conference

Upcoming sector events for UNITED THERAPEUTICS CORPORATION
02/26/21 | 04:35pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

Past sector events for UNITED THERAPEUTICS CORPORATION
02/25/21 | 01:40pmGILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 | 01:40pmEXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
1 483
1 460
1,6%

1 554
Operating income
(EBITDA)
M $
Released
Forecast
Spread

749

766
Operating profit
(EBIT)
M $
Released
Forecast
Spread
594
702
-15%

682
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
639
697
-8,3%

705
Net income
M $
Released
Forecast
Spread
515
553
-6,8%

558
EPS
$
Released
Forecast
Spread
11,5
12,5
-7,9%

12,7
Announcement Date02/24/2021


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q42021 Q1 (e)
Sales
M $
Released
Forecast
Spread
385
362
6,3%

368
Operating income
(EBITDA)
M $
Released
Forecast
Spread

164

186
Operating profit
(EBIT)
M $
Released
Forecast
Spread
65,3
172
-62%

164
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
114
177
-35%

165
Net income
M $
Released
Forecast
Spread
98,8
144
-31%

133
EPS
$
Released
Forecast
Spread
2,19
3,15
-31%

2,97
Announcement Date02/24/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise